Trusted Resources: Education
Scientific literature and patient education texts
Assessing Cognitive Function in Neuromuscular Diseases: A Pilot Study in a Sample of Children and Adolescents
source: Journal of clinical medicine
year: 2021
authors: D'Alessandro R,Ragusa N,Vacchetti M,Rolle E,Rossi F,Brusa C,Davico C,Vitiello B,Mongini T,Ricci FS
summary/abstract:Central nervous system (CNS) involvement has been variously studied in pediatric neuromuscular disorders (NMDs). The primary goal of this study was to assess cognitive functioning in NMDs, and secondary aims were to investigate possible associations of cognitive impairment with motor impairment, neurodevelopmental delay, and genotype. This was a cross-sectional study of 43 pediatric patients, affected by six NMDs. Myotonic dystrophy type 1 (DM1) and glycogen storage disease type 2 (GSD2) patients had a delay on the Bayley-III scales. On Wechsler scales, DMD and DM1 patients showed lower FSIQ scores, with an intellectual disability (ID) in 27% and 50%, respectively. FSIQ was normal in Becker muscular dystrophy (BMD), GSD2, and hereditary motor sensory neuropathy (HMSN) patients, while higher individual scores were found in the spinal muscular atrophy (SMA) group. In the DM1 cohort, lower FSIQ correlated with worse motor performance (ρ = 0.84, < 0.05), and delayed speech acquisition was associated with ID ( = 0.048), with worse cognitive impairment in the congenital than in the infantile form ( = 0.04). This study provides further evidence of CNS in some NMDs and reinforces the need to include cognitive assessment in protocols of care of selected pediatric NMDs.
organization: Section of Child and Adolescent Neuropsychiatry, Department of Public Health and Pediatric Sciences, University of Turin, 10126 Turin, Italy.DOI: 10.3390/jcm10204777
read more
Related Content
-
Genetic Architecture of Motor Neuron DiseasesMotor neuron diseases (MNDs) are rare an...
-
Mass General Spinal Muscular Atrophy (SMA) Multidisciplinary ClinicThe Mass General Spinal Muscular Atrophy...
-
Newborn Screening, Treatment Make Big Difference With Rare Muscle DisorderMateo Medina has never walked or talked....
-
Baby First at UNC to Receive Gene Therapy for SMA, Thanks to Early Check Newborn ScreeningIt was a pregnancy that went relatively ...
-
Screening of Neonatal UK Dried Blood Spots Using a Duplex SMN1 Screening AssaySpinal muscular atrophy (SMA) is an auto...
-
Early Diagnosis of Spinal Muscular AtrophyUntreated spinal muscular atrophy (SMA) ...
-
Parent Perceptions in Choosing Treatment for Infants With Spinal Muscular Atrophy Diagnosed Through Newborn Screenin...Objective: To identify factors parents c...